micro-environment
Showing 1 - 25 of 5,486
Patients With IPF
Completed
- Idiopathic Pulmonary Fibrosis
-
Aarhus, DenmarkAarhus University Hospital, Department of Respiratory Diseases a
Aug 9, 2021
Reactive Hyperemia, Micro RNA, Heart Rate Variability Trial in Copenhagen (Firefighting training exercises with no fire,
Not yet recruiting
- Reactive Hyperemia
- +5 more
- Firefighting training exercises with no fire
- +2 more
-
Copenhagen, DenmarkThe National Research Centre for the Working Environment
Mar 1, 2023
Stress Urinary Incontinence Trial in Portland (Retropubic midurethral sling)
Unknown status
- Stress Urinary Incontinence
- Retropubic midurethral sling
-
Portland, Oregon
- +1 more
Sep 14, 2020
Clinical Trajectory of Resected Hepatocellular Carcinoma
Completed
- Hepatocellular Carcinoma
-
Kuala Lumpur, Malaysia
- +5 more
Jun 7, 2021
Micro-environment Involvement in Muscle Alteration Induced
Completed
- Chronic Obstructive Pulmonary Disease
- +2 more
-
Montpellier, FranceUhmontpellier
Jun 22, 2020
Pulmonary Ventilation Trial in Paris (Exposure measurement, Spirometry test, Exhaled carbon monoxide test)
Completed
- Pulmonary Ventilation
- Exposure measurement
- +4 more
-
Paris, FranceParis Descartes University
Jul 31, 2021
Sensitized Acupoint Changes in Knee Osteoarthritis Patients
Completed
- Microdialysis
- microdialysis
-
Chengdu, Sichuan, ChinaShuguang
Feb 10, 2020
Anal Cancer Trial in Gothenburg (Biopsies)
Not yet recruiting
- Anal Cancer
- Biopsies
-
Gothenburg, SwedenDept. of Surgery, Sahlgrenska University Hospital/Ostra
Jul 3, 2023
Palliative Care Trial in Ankara (Micro-teaching enriched with standard patient)
Recruiting
- Palliative Care
- Micro-teaching enriched with standard patient
-
Ankara, Mamak, TurkeyEsra Tayaz
Apr 24, 2023
PET Tracer Based FDG Signal for Predicting Prognosis in Acute
Enrolling by invitation
- Acute Myeloid Leukemia
- No intervention
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Jinan University
Jun 22, 2023
Hepatocellular Cancer Trial in Clichy (IRM with a 5-minute- additional sequence to measure FRM)
Completed
- Hepatocellular Cancer
- IRM with a 5-minute- additional sequence to measure FRM
-
Clichy, FranceValérie Vilgrain
Jun 20, 2022
Effectiveness in Ovarian Cancer
Completed
- Ovarian Cancer
- +5 more
- Baseline Biopsy
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
Recruiting
- Breast Cancer
- Characterization of breast stem & immune system cells infiltrated in the mammary gland
-
Lyon, FranceCentre Léon Bérard
Aug 26, 2022
Colorectal Adenocarcinoma Trial in Padova (Impact Oral®)
Not yet recruiting
- Colorectal Adenocarcinoma
- Impact Oral®
-
Padova, ItalyIstituto Oncologico Veneto IRCCS
Nov 10, 2023
Healthy, Obesity, Diabetes Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (MR Imaging
Recruiting
- Healthy
- +4 more
- MR Imaging Techniques - 1
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte
Recruiting
- Malignant Neoplasm
- +4 more
- Chimeric Antigen Receptor T-Cell Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Heart Diseases, Cardiovascular Diseases Trial in Ann Arbor, Grand Rapids (Telehealth, Control)
Completed
- Heart Diseases
- Cardiovascular Diseases
- Telehealth
- Control
-
Ann Arbor, Michigan
- +1 more
Nov 21, 2022
Hearing Loss Trial in Aurora (Phonak Audeo hearing aids)
Enrolling by invitation
- Hearing Loss
- Phonak Audeo hearing aids
-
Aurora, IllinoisPhonak Audiology Research Center
Jul 18, 2022
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Boston, New York (Canakinumab injection; spartalizumab, nab-paclitaxel,
Active, not recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
NSCLC Trial in Goyang-Si (CA and Nivolumab)
Recruiting
- Non-small Cell Lung Cancer
- CA and Nivolumab
-
Goyang-Si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Apr 4, 2022
Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,
Not yet recruiting
- Refractory or Recurrent Solid Tumor
- Spartalizumab in Pediatric cohort
- +3 more
-
Angers, France
- +8 more
Mar 9, 2022
Blood Loss, Surgical, Blood Loss, Postoperative Trial in Cairo (Misoprostol)
Recruiting
- Blood Loss, Surgical
- Blood Loss, Postoperative
-
Cairo, EgyptFaculty of medicine, Cairo University
Sep 20, 2023
Recurrent Urinary Tract Infection, Genitourinary Syndrome of Menopause Trial in London (Deka SmartXide Touch C60 (MonaLisa
Recruiting
- Recurrent Urinary Tract Infection
- Genitourinary Syndrome of Menopause
- Deka SmartXide Touch C60 (MonaLisa Touch)
- Sham
-
London, United KingdomKing's College Hospital
Nov 6, 2023
Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)
Completed
- Breast Cancer
- Radiation Toxicity
- Radiotherapy
-
Ghent, Oost-Vlaanderen, Belgium
- +1 more
Jan 3, 2023